Zhejiang Jolly Pharmaceutical Co.,LTD (SHE:300181)
China flag China · Delayed Price · Currency is CNY
12.64
-0.21 (-1.63%)
Nov 18, 2026, 3:04 PM CST

SHE:300181 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
3,2613,0312,5691,9371,7871,450
Other Revenue
9.779.778.955.218.237.26
3,2713,0412,5781,9421,8051,457
Revenue Growth
16.29%17.96%32.71%7.61%23.86%33.60%
Cost of Revenue
1,2811,1781,019616.36534.65420.35
Gross Profit
1,9901,8631,5591,3261,2711,037
Selling, General & Admin
1,2311,090949.08874.18921.45794.25
Research & Development
66.4369.4271.9479.3864.4345.63
Other Operating Expenses
-49.99-54.55-58.7-49.99-42.32-28.31
Operating Expenses
1,2531,112968.57904.42948.8812.78
Operating Income
736.44750.52590.51421.66321.71224.26
Interest Expense
-17.06-14.44-9.29-7.62-8.32-12.07
Interest & Investment Income
2.284.7815.95224.644.41
Currency Exchange Gain (Loss)
-0-000-0-
Other Non Operating Income (Expenses)
6.75-0.23-0.470.18-0.01-1.13
EBT Excluding Unusual Items
728.42740.63596.7436.21318.02215.47
Gain (Loss) on Sale of Investments
-3.12-3.46-0.66-0.10.080.52
Gain (Loss) on Sale of Assets
0.370.590.350.28-9.71-1.92
Asset Writedown
-6.72-1.7-8.06-0.53--
Other Unusual Items
13.6419.618.3610.7815.748.24
Pretax Income
732.59755.67596.69446.64324.12222.31
Income Tax Expense
107.64113.2380.7355.8838.630.33
Earnings From Continuing Operations
624.95642.44515.96390.76285.52191.98
Net Income to Company
624.95642.44515.96390.76285.52191.98
Minority Interest in Earnings
-8.33-10.5-8.19-7.83-12.51-12.58
Net Income
616.63631.93507.77382.94273.01179.41
Net Income to Common
616.63631.93507.77382.94273.01179.41
Net Income Growth
3.42%24.45%32.60%40.27%52.17%102.03%
Shares Outstanding (Basic)
677687696696607619
Shares Outstanding (Diluted)
694694696696607619
Shares Change
-0.28%-0.17%-0.10%14.76%-1.93%1.64%
EPS (Basic)
0.910.920.730.550.450.29
EPS (Diluted)
0.890.910.730.550.450.29
EPS Growth
3.70%24.66%32.73%22.22%55.17%98.77%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
198.54124.6634.16156.75140.56103.84
Free Cash Flow Per Share
0.290.180.050.230.230.17
Dividend Per Share
0.3500.3500.6000.4500.3000.200
Dividend Growth
-41.67%-41.67%33.33%50.00%50.00%100.00%
Gross Margin
60.83%61.25%60.48%68.27%70.38%71.16%
Operating Margin
22.51%24.68%22.91%21.71%17.82%15.39%
Profit Margin
18.85%20.78%19.70%19.71%15.12%12.31%
Free Cash Flow Margin
6.07%4.10%1.32%8.07%7.79%7.12%
EBITDA
816.37825.44658.75483.23378.43277.87
EBITDA Margin
24.96%27.15%25.55%24.88%20.96%19.07%
D&A For EBITDA
79.9274.9268.2461.5856.7253.61
EBIT
736.44750.52590.51421.66321.71224.26
EBIT Margin
22.51%24.68%22.91%21.71%17.82%15.39%
Effective Tax Rate
14.69%14.98%13.53%12.51%11.91%13.64%
Revenue as Reported
3,2713,0412,5781,9421,8051,457
Advertising Expenses
-736.24633.3815.71675.37528.45